Published in J Bone Miner Res on June 18, 2010
Finite element analysis applied to 3-T MR imaging of proximal femur microarchitecture: lower bone strength in patients with fragility fractures compared with control subjects. Radiology (2014) 2.15
Osteoporosis imaging: state of the art and advanced imaging. Radiology (2012) 1.58
Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study. J Bone Miner Res (2015) 1.50
High-resolution computed tomography for clinical imaging of bone microarchitecture. Clin Orthop Relat Res (2011) 1.32
Methods for assessing bone quality: a review. Clin Orthop Relat Res (2011) 1.22
High-resolution peripheral quantitative computed tomography for the assessment of bone strength and structure: a review by the Canadian Bone Strength Working Group. Curr Osteoporos Rep (2013) 1.11
The effect of long-term alendronate treatment on cortical thickness of the proximal femur. Clin Orthop Relat Res (2011) 1.10
Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study. Osteoporos Int (2011) 1.03
Multicenter precision of cortical and trabecular bone quality measures assessed by high-resolution peripheral quantitative computed tomography. J Bone Miner Res (2013) 1.02
Quantitative characterization of subject motion in HR-pQCT images of the distal radius and tibia. Bone (2011) 0.98
Bariatric surgery results in cortical bone loss. J Clin Endocrinol Metab (2013) 0.98
Noninvasive imaging of bone microarchitecture. Ann N Y Acad Sci (2011) 0.98
Effect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats. Bone (2014) 0.96
Clinical imaging of bone microarchitecture with HR-pQCT. Curr Osteoporos Rep (2013) 0.94
Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia-a randomized placebo-controlled trial. Osteoporos Int (2012) 0.94
Feasibility of three-dimensional MRI of proximal femur microarchitecture at 3 tesla using 26 receive elements without and with parallel imaging. J Magn Reson Imaging (2013) 0.92
Longitudinal evaluation of the effects of alendronate on MRI bone microarchitecture in postmenopausal osteopenic women. Bone (2010) 0.90
Age- and gender-related differences in cortical geometry and microstructure: Improved sensitivity by regional analysis. Bone (2012) 0.88
Bone composition: relationship to bone fragility and antiosteoporotic drug effects. Bonekey Rep (2013) 0.88
Quantification of skeletal growth, modeling, and remodeling by in vivo micro computed tomography. Bone (2015) 0.87
In vivo bone architecture in pompe disease using high-resolution peripheral computed tomography. JIMD Rep (2012) 0.85
Postmenopausal women treated with combination parathyroid hormone (1-84) and ibandronate demonstrate different microstructural changes at the radius vs. tibia: the PTH and Ibandronate Combination Study (PICS). Osteoporos Int (2013) 0.85
Bisphosphonates and bone quality. Bonekey Rep (2014) 0.85
Fast trabecular bone strength predictions of HR-pQCT and individual trabeculae segmentation-based plate and rod finite element model discriminate postmenopausal vertebral fractures. J Bone Miner Res (2013) 0.84
Bone morphology in response to alendronate as seen by high-resolution computed tomography: Through a glass darkly. J Bone Miner Res (2010) 0.83
Micro-finite element analysis applied to high-resolution MRI reveals improved bone mechanical competence in the distal femur of female pre-professional dancers. Osteoporos Int (2012) 0.83
Long-term HIV infection and antiretroviral therapy are associated with bone microstructure alterations in premenopausal women. Osteoporos Int (2012) 0.82
Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates. Osteoporos Int (2016) 0.81
Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study). J Clin Endocrinol Metab (2016) 0.81
Characterizing microarchitectural changes at the distal radius and tibia in postmenopausal women using HR-pQCT. Osteoporos Int (2014) 0.81
Effect of parathyroidectomy versus risedronate on volumetric bone mineral density and bone geometry at the tibia in postmenopausal women with primary hyperparathyroidism. J Bone Miner Metab (2013) 0.80
The influence of disuse on bone microstructure and mechanics assessed by HR-pQCT. Bone (2014) 0.80
Single and combined effect of high-frequency loading and bisphosphonate treatment on the bone micro-architecture of ovariectomized rats. Osteoporos Int (2014) 0.79
Predicting mouse vertebra strength with micro-computed tomography-derived finite element analysis. Bonekey Rep (2015) 0.79
A Trimodality Comparison of Volumetric Bone Imaging Technologies. Part II: 1-Yr Change, Long-Term Precision, and Least Significant Change. J Clin Densitom (2014) 0.78
Growth and Age-Related Abnormalities in Cortical Structure and Fracture Risk. Endocrinol Metab (Seoul) (2015) 0.78
Bone strength and management of postmenopausal fracture risk with antiresorptive therapies: considerations for women's health practice. Int J Womens Health (2016) 0.77
Least significant changes and monitoring time intervals for high-resolution pQCT-derived bone outcomes in postmenopausal women. J Musculoskelet Neuronal Interact (2015) 0.77
Cortical remodeling during menopause, rheumatoid arthritis, glucocorticoid and bisphosphonate therapy. Arthritis Res Ther (2013) 0.77
Quantitative assessment of trabecular bone micro-architecture of the wrist via 7 Tesla MRI: preliminary results. MAGMA (2011) 0.77
Letter to the editor: the effect of long-term alendronate treatment on cortical thickness of the proximal femur. Clin Orthop Relat Res (2011) 0.76
Intrinsic mechanical behavior of femoral cortical bone in young, osteoporotic and bisphosphonate-treated individuals in low- and high energy fracture conditions. Sci Rep (2016) 0.76
Longitudinal Change in Trabecular Bone Score during and after Treatment of Osteoporosis in Postmenopausal Korean Women. J Bone Metab (2017) 0.75
In vivo precision of three HR-pQCT-derived finite element models of the distal radius and tibia in postmenopausal women. BMC Musculoskelet Disord (2016) 0.75
A New Algorithm for Cortical Bone Segmentation with Its Validation and Applications to In Vivo Imaging. Proc Int Conf Image Anal Process (2013) 0.75
Validation of a new multiscale finite element analysis approach at the distal radius. Med Eng Phys (2017) 0.75
Automated cortical bone segmentation for multirow-detector CT imaging with validation and application to human studies. Med Phys (2015) 0.75
In vivo evaluation of bone microstructure in humans: Clinically useful? Bonekey Rep (2016) 0.75
Osteoporosis drug effects on cortical and trabecular bone microstructure: a review of HR-pQCT analyses. Bonekey Rep (2016) 0.75
Cortical bone laminar analysis reveals increased midcortical and periosteal porosity in type 2 diabetic postmenopausal women with history of fragility fractures compared to fracture-free diabetics. Osteoporos Int (2016) 0.75
Cortical thinning and progressive cortical porosity in female patients with systemic lupus erythematosus on long-term glucocorticoids: a 2-year case-control study. Osteoporos Int (2015) 0.75
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (1987) 24.27
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser (1994) 17.37
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet (1996) 13.20
In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab (2005) 5.31
BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res (2003) 4.64
In vivo high resolution 3D-QCT of the human forearm. Technol Health Care (1998) 3.49
Structural trends in the aging femoral neck and proximal shaft: analysis of the Third National Health and Nutrition Examination Survey dual-energy X-ray absorptiometry data. J Bone Miner Res (2000) 3.36
Finite element analysis based on in vivo HR-pQCT images of the distal radius is associated with wrist fracture in postmenopausal women. J Bone Miner Res (2008) 3.33
Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study. J Bone Miner Res (2007) 3.31
Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res (2005) 3.11
Automatic segmentation of cortical and trabecular compartments based on a dual threshold technique for in vivo micro-CT bone analysis. Bone (2007) 2.66
Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone (2004) 2.48
Age- and gender-related differences in the geometric properties and biomechanical significance of intracortical porosity in the distal radius and tibia. J Bone Miner Res (2010) 2.39
Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate. J Bone Miner Res (2010) 2.37
Postmenopausal women with osteopenia have higher cortical porosity and thinner cortices at the distal radius and tibia than women with normal aBMD: an in vivo HR-pQCT study. J Bone Miner Res (2010) 2.34
A new method to determine trabecular bone elastic properties and loading using micromechanical finite-element models. J Biomech (1995) 2.28
Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone (2000) 2.24
Contribution of in vivo structural measurements and load/strength ratios to the determination of forearm fracture risk in postmenopausal women. J Bone Miner Res (2007) 2.11
High-resolution pQCT analysis at the distal radius and tibia discriminates patients with recent wrist and femoral neck fractures. J Bone Miner Res (2008) 2.04
Ridge number density: a new parameter for in vivo bone structure analysis. Bone (1997) 2.03
Consensus development conference: prophylaxis and treatment of osteoporosis. Am J Med (1991) 2.00
Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. J Bone Miner Res (2002) 1.81
Direct mechanics assessment of elastic symmetries and properties of trabecular bone architecture. J Biomech (1996) 1.79
In vivo determination of bone structure in postmenopausal women: a comparison of HR-pQCT and high-field MR imaging. J Bone Miner Res (2008) 1.79
Improved reproducibility of high-resolution peripheral quantitative computed tomography for measurement of bone quality. Med Eng Phys (2008) 1.72
Comparison of structure extraction methods for in vivo trabecular bone measurements. Comput Med Imaging Graph (1999) 1.50
Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study. J Bone Miner Res (2005) 1.42
Bone micro-architecture and determinants of strength in the radius and tibia: age-related changes in a population-based study of normal adults measured with high-resolution pQCT. Osteoporos Int (2009) 1.30
Three-dimensional finite element modelling of non-invasively assessed trabecular bone structures. Med Eng Phys (1995) 1.23
Mechanisms of the anabolic effects of teriparatide on bone: insight from the treatment of a patient with pycnodysostosis. J Bone Miner Res (2008) 1.19
Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture. J Bone Miner Res (2001) 1.18
Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib. Calcif Tissue Int (2006) 1.18
Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney disease. J Bone Miner Res (2010) 1.16
Site-specific variation of bone micro-architecture in the distal radius and tibia. J Clin Densitom (2008) 1.15
Risedronate reduces intracortical porosity in women with osteoporosis. J Bone Miner Res (2010) 1.15
The effects of geometric and threshold definitions on cortical bone metrics assessed by in vivo high-resolution peripheral quantitative computed tomography. Calcif Tissue Int (2007) 1.14
Regional variations of gender-specific and age-related differences in trabecular bone structure of the distal radius and tibia. Bone (2010) 1.12
Three dimensional cancellous bone structure in hypoparathyroidism. Bone (2009) 1.12
Accuracy of volumetric bone mineral density measurement in high-resolution peripheral quantitative computed tomography. Bone (2009) 1.05
High-resolution peripheral QCT imaging of bone micro-structure in adolescents. Osteoporos Int (2009) 1.04
Image-based assessment of spinal trabecular bone structure from high-resolution CT images. Osteoporos Int (1998) 1.01
Structure analysis of high resolution magnetic resonance imaging of the proximal femur: in vitro correlation with biomechanical strength and BMD. Calcif Tissue Int (2002) 0.95
Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab (2005) 5.64
Osteoarthritis: MR imaging findings in different stages of disease and correlation with clinical findings. Radiology (2003) 3.36
T2 relaxation time of cartilage at MR imaging: comparison with severity of knee osteoarthritis. Radiology (2004) 3.24
The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A (2004) 3.15
Quantitative MRI of cartilage and bone: degenerative changes in osteoarthritis. NMR Biomed (2006) 2.64
Age- and gender-related differences in the geometric properties and biomechanical significance of intracortical porosity in the distal radius and tibia. J Bone Miner Res (2010) 2.39
A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation. J Clin Invest (2006) 2.39
Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice. Proc Natl Acad Sci U S A (2004) 2.39
Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate. J Bone Miner Res (2010) 2.37
Reproducibility of direct quantitative measures of cortical bone microarchitecture of the distal radius and tibia by HR-pQCT. Bone (2010) 2.32
Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. Radiology (2005) 2.25
Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study. J Bone Miner Res (2004) 2.23
T2 relaxation time measurements in osteoarthritis. Magn Reson Imaging (2004) 2.06
In vivo T(1rho) mapping in cartilage using 3D magnetization-prepared angle-modulated partitioned k-space spoiled gradient echo snapshots (3D MAPSS). Magn Reson Med (2008) 2.01
The treatment mechanism of an interspinous process implant for lumbar neurogenic intermittent claudication. Spine (Phila Pa 1976) (2005) 1.97
Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures. J Bone Miner Res (2013) 1.96
MR imaging of therapy-induced changes of bone marrow. Eur Radiol (2006) 1.95
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial. Lancet Oncol (2012) 1.94
Changes in bone structure and mass with advancing age in the male C57BL/6J mouse. J Bone Miner Res (2002) 1.94
Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years. J Clin Endocrinol Metab (2006) 1.88
In vivo determination of bone structure in postmenopausal women: a comparison of HR-pQCT and high-field MR imaging. J Bone Miner Res (2008) 1.79
Inter-subject comparison of MRI knee cartilage thickness. Med Image Anal (2007) 1.73
Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J Bone Miner Res (2002) 1.73
Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology (2003) 1.72
Analysis of vertebral morphology in idiopathic scoliosis with use of magnetic resonance imaging and multiplanar reconstruction. J Bone Joint Surg Am (2002) 1.71
Cartilage in anterior cruciate ligament-reconstructed knees: MR imaging T1{rho} and T2--initial experience with 1-year follow-up. Radiology (2010) 1.70
In vivo 3T spiral imaging based multi-slice T(1rho) mapping of knee cartilage in osteoarthritis. Magn Reson Med (2005) 1.66
High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab (2010) 1.64
In vivo intervertebral disc characterization using magnetic resonance spectroscopy and T1ρ imaging: association with discography and Oswestry Disability Index and Short Form-36 Health Survey. Spine (Phila Pa 1976) (2012) 1.59
T1rho, T2 and focal knee cartilage abnormalities in physically active and sedentary healthy subjects versus early OA patients--a 3.0-Tesla MRI study. Eur Radiol (2008) 1.56
Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures. J Bone Miner Res (2013) 1.55
Quantitative MRI using T1ρ and T2 in human osteoarthritic cartilage specimens: correlation with biochemical measurements and histology. Magn Reson Imaging (2010) 1.53
Morbidity of direct MR arthrography. AJR Am J Roentgenol (2011) 1.53
Spatial distribution and relationship of T1rho and T2 relaxation times in knee cartilage with osteoarthritis. Magn Reson Med (2009) 1.52
A local adaptive threshold strategy for high resolution peripheral quantitative computed tomography of trabecular bone. Ann Biomed Eng (2007) 1.49
Patellar cartilage: T2 values and morphologic abnormalities at 3.0-T MR imaging in relation to physical activity in asymptomatic subjects from the osteoarthritis initiative. Radiology (2009) 1.47
MR imaging findings in the follow-up of patients with different stages of knee osteoarthritis and the correlation with clinical symptoms. Eur Radiol (2005) 1.45
Relationship between trabecular bone structure and articular cartilage morphology and relaxation times in early OA of the knee joint using parallel MRI at 3 T. Osteoarthritis Cartilage (2008) 1.44
MRI and CT of insufficiency fractures of the pelvis and the proximal femur. AJR Am J Roentgenol (2008) 1.44
A pilot, two-year longitudinal study of the interrelationship between trabecular bone and articular cartilage in the osteoarthritic knee. Osteoarthritis Cartilage (2004) 1.41
Combined image processing techniques for characterization of MRI cartilage of the knee. Conf Proc IEEE Eng Med Biol Soc (2005) 1.39
Meniscal measurements of T1rho and T2 at MR imaging in healthy subjects and patients with osteoarthritis. Radiology (2008) 1.37
7T human spine imaging arrays with adjustable inductive decoupling. IEEE Trans Biomed Eng (2009) 1.37
In vivo 3.0-tesla magnetic resonance T1rho and T2 relaxation mapping in subjects with intervertebral disc degeneration and clinical symptoms. Magn Reson Med (2010) 1.35
IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone. J Bone Miner Res (2007) 1.32
High-resolution computed tomography for clinical imaging of bone microarchitecture. Clin Orthop Relat Res (2011) 1.32
MRI analysis of in vivo meniscal and tibiofemoral kinematics in ACL-deficient and normal knees. J Orthop Res (2006) 1.32
The osteoclast, bone remodelling and treatment of metabolic bone disease. Eur J Clin Invest (2012) 1.31
Comparison of quantitative imaging of cartilage for osteoarthritis: T2, T1rho, dGEMRIC and contrast-enhanced computed tomography. Magn Reson Imaging (2009) 1.29
Quantitative assessment of bone marrow edema-like lesion and overlying cartilage in knees with osteoarthritis and anterior cruciate ligament tear using MR imaging and spectroscopic imaging at 3 Tesla. J Magn Reson Imaging (2008) 1.29
Automated registration of hip and spine for longitudinal QCT studies: integration with 3D densitometric and structural analysis. Bone (2005) 1.29
A feasibility study of in vivo T1rho imaging of the intervertebral disc. Magn Reson Imaging (2006) 1.29
Detection of posttraumatic cartilage injury using quantitative T1rho magnetic resonance imaging. A report of two cases with arthroscopic findings. J Bone Joint Surg Am (2006) 1.29
Spatial analysis of magnetic resonance T1rho and T2 relaxation times improves classification between subjects with and without osteoarthritis. Med Phys (2009) 1.27
Normalized cuts in 3-D for spinal MRI segmentation. IEEE Trans Med Imaging (2004) 1.27
Magnetic resonance imaging of 3-dimensional in vivo tibiofemoral kinematics in anterior cruciate ligament-reconstructed knees. Arthroscopy (2009) 1.27
Does vertebral bone marrow fat content correlate with abdominal adipose tissue, lumbar spine bone mineral density, and blood biomarkers in women with type 2 diabetes mellitus? J Magn Reson Imaging (2011) 1.26
Quantification of vertebral bone marrow fat content using 3 Tesla MR spectroscopy: reproducibility, vertebral variation, and applications in osteoporosis. J Magn Reson Imaging (2011) 1.26
Prevalence of pathologic findings in asymptomatic knees of marathon runners before and after a competition in comparison with physically active subjects-a 3.0 T magnetic resonance imaging study. Skeletal Radiol (2008) 1.25
Advances in osteoporosis imaging. Eur J Radiol (2009) 1.25
Imaging of the musculoskeletal system in vivo using ultra-high field magnetic resonance at 7 T. Invest Radiol (2009) 1.25
Quantitative assessment of bone tissue mineralization with polychromatic micro-computed tomography. Calcif Tissue Int (2008) 1.24
Rapid in vivo musculoskeletal MR with parallel imaging at 7T. Magn Reson Med (2008) 1.24
Texture analysis of cartilage T2 maps: individuals with risk factors for OA have higher and more heterogeneous knee cartilage MR T2 compared to normal controls--data from the osteoarthritis initiative. Arthritis Res Ther (2011) 1.22
Radiation exposure in X-ray-based imaging techniques used in osteoporosis. Eur Radiol (2010) 1.22
A comparative study at 3 T of sequence dependence of T2 quantitation in the knee. Magn Reson Imaging (2008) 1.22
Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial. J Clin Endocrinol Metab (2013) 1.21
Trabecular bone microarchitecture is deteriorated in men with spinal cord injury. J Bone Miner Res (2004) 1.21
GRAPPA-based susceptibility-weighted imaging of normal volunteers and patients with brain tumor at 7 T. Magn Reson Imaging (2008) 1.20
Tolerability of once-weekly alendronate in patients with osteoporosis: a randomized, double-blind, placebo-controlled study. Mayo Clin Proc (2002) 1.19
Simultaneous acquisition of T1ρ and T2 quantification in knee cartilage: repeatability and diurnal variation. J Magn Reson Imaging (2013) 1.17
In vivo bone and cartilage MRI using fully-balanced steady-state free-precession at 7 tesla. Magn Reson Med (2007) 1.17